Malaria in pregnancy (MiP) contributes to devastating maternal and neonatal outcomes, including maternal anemia, maternal death, stillbirth, spontaneous abortion, and low birth weight, with an estimated 10,000 women and 100,000 infants dying as a result of MiP. In sub-Saharan Africa, MiP contributes to an estimated 20% of all stillbirths and 11% of all newborn deaths.1 National Malaria Control Programs (NMCPs) and Reproductive/Maternal Health (R/MH) Programs must work together to review and address the barriers to achieving MiP program targets and impact. The creation, re-establishment, or strengthening of MiP working groups—bringing together representatives from NMCP, R/MH Programs, and other key partners supporting MiP programming—has been documented as a best practice to foster integration, harmonization, and prioritization of MiP programming.
mip_twg_quick_start_guide_en.zip